Compare · ACON vs ELV
ACON vs ELV
Side-by-side comparison of Aclarion Inc. (ACON) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACON and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $85.49B, about 15161.7x ACON ($5.6M).
- Over the past year, ACON is down 68.9% and ELV is up 35.5% - ELV leads by 104.4 points.
- ACON has been more active in the news (4 items in the past 4 weeks vs 1 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 0 for ACON).
- Company
- Aclarion Inc.
- Elevance Health Inc.
- Price
- $2.26-3.83%
- $394.22+0.71%
- Market cap
- $5.6M
- $85.49B
- 1M return
- -22.34%
- -6.26%
- 1Y return
- -68.87%
- +35.48%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 4
- 1
- Recent ratings
- 0
- 23
Aclarion Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ACON
- SEC Form 10-Q filed by Aclarion Inc.
- Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
- Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
- Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
- SEC Form S-8 filed by Aclarion Inc.
- Aclarion Announces Texas Spine Care Center as New CLARITY Site
- Chief Strategy Officer Bond Ryan was granted 55,000 shares (SEC Form 4)
- Executive Chairman Thramann Jeffrey John was granted 100,000 shares (SEC Form 4)
- Chief Financial Officer Gould Gregory A was granted 50,000 shares (SEC Form 4)
- Director Sequira Amanda Mae was granted 20,000 shares (SEC Form 4)
Latest ELV
- Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS